IFNA1 and systemic lupus erythematosus: Furthermore, these IFN-related changes were prominent in active and quiescent stages of the disease; this suggests that the hypersensitivity to IFN mediated through epigenetics persists beyond the acute stages of SLE, acting independently of circulatory IFN levels.